Skip to main content

Table 4 Incidence of new-onset diabetes according to the number of metabolic syndrome components during the 3-year follow-up

From: Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up

Number of metabolic syndrome componentsIncidence of new-onset diabetesHR (95% CI)p-value
Pitavastatin 1 mgPitavastatin 4 mg
14/501/510.23 (0.03, 2.13)0.20
25/964/1000.75 (0.20, 2.91)0.69
34/732/740.48 (0.09, 2.70)0.40
41/322/262.58 (0.22, 30.20)0.45
Overall14/2519/2510.67 (0.27, 1.64)0.38